Table of Contents Author Guidelines Submit a Manuscript
Sarcoma
Volume 2017 (2017), Article ID 7495914, 6 pages
https://doi.org/10.1155/2017/7495914
Research Article

Early Evidence of Cardiotoxicity and Tumor Response in Patients with Sarcomas after High Cumulative Dose Doxorubicin Given as a Continuous Infusion

1Department of Cardiology, University of Texas MD Anderson Cancer Center, 1515 Holcombe Blvd., Unit 1451, Houston, TX 77030, USA
2Division of Hematology/Oncology, Department of Medicine, Medical University of South Carolina, Charleston, SC 29425, USA
3Department of Sarcoma Medical Oncology, University of Texas MD Anderson Cancer Center, 1515 Holcombe Boulevard, Unit 450, Houston, TX 77030, USA

Correspondence should be addressed to Raymundo A. Quintana; ude.yrome@tniuqar

Received 16 June 2017; Accepted 20 August 2017; Published 26 September 2017

Academic Editor: Fritz C. Eilber

Copyright © 2017 Raymundo A. Quintana et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

How to Cite this Article

Raymundo A. Quintana, Jose Banchs, Ridhi Gupta, et al., “Early Evidence of Cardiotoxicity and Tumor Response in Patients with Sarcomas after High Cumulative Dose Doxorubicin Given as a Continuous Infusion,” Sarcoma, vol. 2017, Article ID 7495914, 6 pages, 2017. doi:10.1155/2017/7495914